Atlas Trials

OptiMATe: De-escalated Induction Treatment in Primary CNS Lymphoma

Clinical trial NCT04931368 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04931368
Sponsor
Klinikum Stuttgart
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Primary Central Nervous System Lymphoma
Start date
2021-06-28
Primary completion
2028-06-01
Enrollment
331

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.